Dimethyl Fumarate Treatment for Intracranial Unruptured Aneurysms.

Phase 4 Unknown 60 enrolled Beijing Tiantan Hospital Beijing Chao Yang Hospital · collab Beijing Neurosurgical Institute · collab Henan Provincial People's Hospital · collab

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study was designed to identify whether there is a measurable reduction in inflammation in walls of intracranial aneurysms with oral dimethyl fumarate.

Timeline

Start: 2023-07-31
Primary completion: 2023-12-31
Completion: 2024-06-01

Publications

Huang J, Zhang Y, Turhon M, Zheng Z, Li W, Kang H, Wang C, Liu J, Jiang P. Dimethyl fumarate treatment for unruptured intracranial aneurysms: a study protocol for a double-blind randomised controlled trial. BMJ Open. 2024 May 21;14(5):e080333. doi: 10.1136/bmjopen-2023-080333.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	dimethyl fumarate	Unknown	240 mg	Oral

Dimethyl Fumarate Treatment for Intracranial Unruptured Aneurysms.

Summary

Timeline

Publications

Drugs

Indications